carnosine has been researched along with Eye Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crook, D; Deoraj, P; Gopinath, C; Green, OP; Matsuda, K | 1 |
Babizhayev, MA | 1 |
Babizhayev, MA; Yegorov, YE | 1 |
Babizhayev, MA; Kasus-Jacobi, A; Khoroshilova-Maslova, IP | 1 |
3 review(s) available for carnosine and Eye Diseases
Article | Year |
---|---|
Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships.
Topics: Administration, Topical; Antioxidants; Carnosine; Drug Delivery Systems; Eye Diseases; Humans; Ophthalmic Solutions; Patents as Topic | 2009 |
Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of a
Topics: Aging; Animals; Biomarkers; Carnosine; Chemistry, Pharmaceutical; Chronic Disease; Drug Carriers; Drug Compounding; Drug Design; Eye Diseases; Glycation End Products, Advanced; Humans; Lens, Crystalline; Lipid Peroxidation; Models, Molecular; Molecular Structure; Oxidative Stress; Skin; Skin Aging; Skin Diseases; Structure-Activity Relationship | 2010 |
Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care.
Topics: Administration, Ophthalmic; Animals; Carnosine; Cataract; Chromatography, High Pressure Liquid; Clinical Trials, Phase II as Topic; Drug Delivery Systems; Eye Diseases; Humans; Prodrugs; Randomized Controlled Trials as Topic; Vitreoretinopathy, Proliferative | 2012 |
1 other study(ies) available for carnosine and Eye Diseases
Article | Year |
---|---|
Toxicity of the novel anti-peptic ulcer agent catena-(S)-[mu-[Na- (3-aminopropionyl)histidinato(2-)-N1,N2,Q:N tau]-zinc in male cynomolgus monkeys.
Topics: Animals; Anti-Ulcer Agents; Body Weight; Carnosine; Copper; Dipeptides; Eating; Electrocardiography; Eye Diseases; Female; Iron; Macaca fascicularis; Male; Organometallic Compounds; Piloerection; Vomiting; Zinc; Zinc Compounds | 1993 |